These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19963387)

  • 1. Data presentation in rodent stroke studies and the predictive value of confidence intervals.
    Sughrue ME; Grobelny BT; Ducruet AF; Komotar RJ; Mocco J; Sciacca RR; Sander Connolly E
    J Clin Neurosci; 2010 Jan; 17(1):11-5. PubMed ID: 19963387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
    Savitz SI
    Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,026 experimental treatments in acute stroke.
    O'Collins VE; Macleod MR; Donnan GA; Horky LL; van der Worp BH; Howells DW
    Ann Neurol; 2006 Mar; 59(3):467-77. PubMed ID: 16453316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke.
    Bath PM; Macleod MR; Green AR
    Int J Stroke; 2009 Dec; 4(6):471-9. PubMed ID: 19930059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin reduces infarct volume but not edema formation in acute stroke.
    Walberer M; Nedelmann M; Ritschel N; Mueller C; Tschernatsch M; Stolz E; Bachmann G; Blaes F; Gerriets T
    Neuroimmunomodulation; 2010; 17(2):97-102. PubMed ID: 19923854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of time-dependent reduction of histologically determined infarct volume after focal ischaemia in mice.
    Henrich-Noack P; Baldauf K; Reiser G; Reymann KG
    Neurosci Lett; 2008 Feb; 432(2):141-5. PubMed ID: 18222610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models.
    Kohara A; Takahashi M; Yatsugi S; Tamura S; Shitaka Y; Hayashibe S; Kawabata S; Okada M
    Brain Res; 2008 Jan; 1191():168-79. PubMed ID: 18164695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
    Vakili A; Zahedi-Khorasani M
    Pak J Pharm Sci; 2008 Jan; 21(1):24-8. PubMed ID: 18166515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect size, confidence interval and statistical significance: a practical guide for biologists.
    Nakagawa S; Cuthill IC
    Biol Rev Camb Philos Soc; 2007 Nov; 82(4):591-605. PubMed ID: 17944619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroprotection in brain ischemia--doubts and hopes].
    Zádor Z; Benyó Z; Lacza Z; Hortobágyi T; Harkány T; Hortobágyi T
    Ideggyogy Sz; 2004 Mar; 57(3-4):81-93. PubMed ID: 15133909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model.
    Royl G; Balkaya M; Lehmann S; Lehnardt S; Stohlmann K; Lindauer U; Endres M; Dirnagl U; Meisel A
    Brain Res; 2009 Apr; 1265():148-57. PubMed ID: 19368809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using behaviour to predict stroke severity in conscious rats: post-stroke treatment with 3', 4'-dihydroxyflavonol improves recovery.
    Roulston CL; Callaway JK; Jarrott B; Woodman OL; Dusting GJ
    Eur J Pharmacol; 2008 Apr; 584(1):100-10. PubMed ID: 18316070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion.
    Limatola V; Ward P; Cattano D; Gu J; Giunta F; Maze M; Ma D
    Neuroscience; 2010 Feb; 165(3):874-81. PubMed ID: 19895874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.
    Sevimli S; Diederich K; Strecker JK; Schilling M; Klocke R; Nikol S; Kirsch F; Schneider A; Schäbitz WR
    Exp Neurol; 2009 Jun; 217(2):328-35. PubMed ID: 19332060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of nitroglycerin in a rodent model of ischemic stroke: evaluation of Bcl-2 expression.
    Greco R; Amantea D; Blandini F; Nappi G; Bagetta G; Corasaniti MT; Tassorelli C
    Int Rev Neurobiol; 2007; 82():423-35. PubMed ID: 17678976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia.
    Cimino M; Balduini W; Carloni S; Gelosa P; Guerrini U; Tremoli E; Sironi L
    Neurotoxicology; 2005 Oct; 26(5):929-33. PubMed ID: 15923039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.